We will be closed December 24th-26th for Christmas. Happy Holidays!
Procedures
Optilight IPL
In our Optilight IPL procedure, a trained practitioner makes use of a specialized tool to rejuvenate the patient's meibomian glands and alleviate meibomian gland dysfunction. The tool utilizes a combination of visual and infrared light which penetrates the skins surface and acts directly on the glands themselves, restoring proper function and blood flow.
Lipiflow
During a Lipiflow, patients meibomian glands are gently massaged by the patented Lipiflow Thermal Pulsation System, which works both over and under the eyelids. This often clears blockages in the tear pathway that contribute to symptoms of Dry Eye Syndrome, and revitalizes bloodflow to the eyelids long after treatment has concluded.
Blephex
Blephex is specifically designed as a treatment for blepharitis, or inflammation of the eyelids. Our Blephex procedure uses a fast-spinning, medical grade micro sponge to gently clean the glandular exits on a patient's eyelids. Secretions from glands that line the eyelids often cause blockages, resulting in discomfort, dryness and other symptoms of Dry Eye Syndrome.
Neurolens
" For patients with chronic Dry Eye, we often find that correcting vision with proper lenses can significantly alleviate symptoms. "
Among the more effective remedies is Neurolens, a unique spectacle lens that uses a contoured prism design to assist your eyes' ability to work as a team - thus alleviating ocular headaches, pain, and surface level irritation that may initially appear as an unrelated issue.
Medications and Lifestyle Interventions
Our Doctors may also recommend a number of other remedies depending on your symptoms. Over the counter medications and lifestyle changes can be key factors in maintaining proper eye health in the long term. In addition, a number of prescription medications can be standout solutions for some patients. See Below.
Xiidra®
What is Xiidra®?
Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease. Xiidra targets a source of inflammation that may cause dry eye disease. Dry eye disease can be caused by inflammation on the surface of the eye. Xiidra® is specifically designed to target a source of that inflammation.
Xiidra has been studied in more than 1,000 patients with dry eye in four separate, 12-week clinical studies. Xiidra was proven to reduce symptoms of eye dryness in all four studies and Inferior fluorescein Corneal Staining Score in three of the four studies in some patients at week 12.
Xiidra may not work for everyone. Ask your doctor if Xiidra is right for you.
IMPORTANT SAFETY INFORMATION
Do not use Xiidra if you are allergic to any of its ingredients. Seek medical care immediately if you get any symptoms of an allergic reaction.
The most common side effects of Xiidra include eye irritation, discomfort or blurred vision when the drops are applied to the eyes, and an unusual taste sensation.
To help avoid eye injury or contamination of the solution, do not touch the container tip to your eye or any surface. If you wear contact lenses, remove them before using Xiidra and wait for at least 15 minutes before placing them back in your eyes.
It is not known if Xiidra is safe and effective in children under 17 years of age.
Vital Tears™
What is Vital Tears?™
Vital Tears™ are a special type of prescription eyedrop called serum tears. Ophthalmologists and optometrists have offered serum tears to their patients for over 30 years to treat symptoms of Dry Eye Syndrome. Also known as Autologous serum eye drops (ASEDs), and autologous serum tears (ASTs), this medication is a customized eye drop synthesized from a patient’s own blood.
Vital Tears are:
PRESERVATIVE FREE – Vital Tears are preservative-free.
CUSTOM MADE – Vital Tears are custom made to provide optimal doses as advised by a patient’s physician.
SAFE – Vital Tears are processed in a medical laboratory with validated safety procedures.
MICROFILTERED – Vital Tears are microfiltered to remove pathogens.
Cequa®
Cequa
CEQUA is the first and only chronic dry eye treatment formulated with NCELL® Technology. In clinical trials, more people treated with CEQUA saw a significant improvement in tear production compared to those not taking CEQUA.
CEQUA was studied in 2 clinical trials totaling 1048 people with chronic dry eye. In both studies, a significantly higher percentage of people treated with CEQUA achieved a clinically relevant improvement in tear production compared to those not taking CEQUA (approximately 17% vs 9%).*
IMPORTANT SAFETY INFORMATION
Do not use CEQUA if you are allergic to any of its ingredients. Be careful not to allow the vial tip to touch your eye or any surfaces, to help avoid potential eye injury or contamination of the product.
CEQUA should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to using CEQUA and may be reinserted after 15 minutes.
Put one drop of CEQUA twice daily (approximately 12 hours apart) into each eye using a single-use vial. The solution should be used immediately after opening, and discard the vial and remaining contents immediately after using.
The most common side effects that may be experienced while using CEQUA include: eye pain after administering drops and eye redness. Other side effects reported were eye irritation, eyelid inflammation, headache, and urinary tract infection.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
RESTASIS®
What is RESTASIS® Ophthalmic Emulsion?
RESTASIS® is the only prescription eye drop that helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® Ophthalmic Emulsion did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.
IMPORTANT SAFETY INFORMATION
Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.
The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.